People: Syngenta AG (SYNN.VX)

SYNN.VX on Virt-X Level 1

348.50CHF
17 Apr 2014
Price Change (% chg)

CHF4.30 (+1.25%)
Prev Close
CHF344.20
Open
CHF342.10
Day's High
CHF348.50
Day's Low
CHF341.10
Volume
469,936
Avg. Vol
427,213
52-wk High
CHF400.90
52-wk Low
CHF302.10

Search Stocks

Lawrence, David 

Brief Biography

Mr. David Lawrence is Non-Executive Independent Director of Syngenta AG since 2009. He is Member of the Audit Committee and also Chairman of the Science and Technology Advisory Board. He was Head Research & Development at Syngenta AG from September 2002 until September 30, 2008. Prior to this role, Mr. Lawrence was Head Research & Technology Projects (2000–Septemer 2002) for Syngenta AG . Prior to this, he was Head International R&D Projects for Zeneca Agrochemicals, having previously held several senior scientific roles. He was a member of the UK Foresight Lead Experience Group on Food and Farming. Currently he is a member of the BBSRC Council and of the UK Industrial Biotechnology Leadership Team. He is also a Board member for Rothamsted Research, Chairman of the UK Biosciences Knowledge Transfer Network Board, and a member of the World Economic Forum Biotechnology Council. Mr. David Lawrence graduated in Chemistry from Oxford University with an MA and DPhil in Chemical Pharmacology.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
322,632 -- -- 322,632

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michel Demare

1,422,000

Michael Mack

--

Juerg Witmer

451,249

John Ramsay

--

John Atkin

--

Davor Pisk

--
As Of 30 Dec 2013
Search Stocks